Literature DB >> 2852029

The prognostic influence of serum neuron specific enolase in small cell lung cancer.

L G Jørgensen1, K Osterlind, H H Hansen, E H Cooper.   

Abstract

An analysis of prognostic factors in small cell lung cancer has been made using presentation data from 86 of 101 consecutive patients referred to The Finsen Institute for chemotherapy. Prognosis was in univariate analysis significantly correlated with performance status (PS), disease extent, serum lactate dehydrogenase (LDH), neuron specific enolase (NSE), alpha-1-acid glycoprotein and plasma sodium. Multivariate analysis, taking stage of disease into account, resulted in selection of PS and NSE as the most influential of the investigated variables. LDH was excluded as an independent prognosticator, but there was a strong correlation between the influence of LDH and NSE (coefficient: -0.38) as well as between their serum concentrations (coefficient: 0.72). LDH and NSE apparently have similar prognostic influence, and NSE seems superior to LDH. A firm conclusion should, however, await our investigation of a large series of patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852029      PMCID: PMC2246866          DOI: 10.1038/bjc.1988.313

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

1.  Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging.

Authors:  M D Vincent; S E Ashley; I E Smith
Journal:  Eur J Cancer Clin Oncol       Date:  1987-11

2.  Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients.

Authors:  T Cerny; V Blair; H Anderson; V Bramwell; N Thatcher
Journal:  Int J Cancer       Date:  1987-02-15       Impact factor: 7.396

3.  Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer.

Authors:  G M Akoun; H M Scarna; B J Milleron; M P Bénichou; D P Herman
Journal:  Chest       Date:  1985-01       Impact factor: 9.410

4.  Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung.

Authors:  R L Souhami; I Bradbury; D M Geddes; S G Spiro; P G Harper; J S Tobias
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

5.  Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation.

Authors:  K Osterlind; P K Andersen
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

6.  Monitoring the therapy of lung cancer with alpha-1-acid glycoprotein.

Authors:  P A Ganz; M Baras; P Y Ma; R M Elashoff
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

7.  Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9.

Authors:  G F Buccheri; D Ferrigno; A M Sartoris; B Violante; F Vola; A Curcio
Journal:  Cancer       Date:  1987-07-01       Impact factor: 6.860

8.  Survival with inoperable lung cancer: an integration of prognostic variables based on simple clinical criteria.

Authors:  V J Lanzotti; D R Thomas; L E Boyle; T L Smith; E A Gehan; M L Samuels
Journal:  Cancer       Date:  1977-01       Impact factor: 6.860

9.  Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancer.

Authors:  J P Sculier; R Feld; W K Evans; F A Shepherd; G DeBoer; D G Malkin; A Malkin
Journal:  J Clin Oncol       Date:  1985-10       Impact factor: 44.544

10.  Prognostic factors for survival in patients with inoperable lung cancer.

Authors:  K E Stanley
Journal:  J Natl Cancer Inst       Date:  1980-07       Impact factor: 13.506

  10 in total
  15 in total

Review 1.  The impact of surgery on the multidisciplinary treatment of bronchogenic small cell carcinoma (updated review including ongoing studies).

Authors:  W Theuer; O Selawry; K Karrer
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

2.  [Neuron-specific enolase: a serum marker of clinical progression for metastatic malignant melanoma].

Authors:  H B Guo; B Stoffel-Wagner; W Brennemann; W Springer; D Klingmüller
Journal:  J Tongji Med Univ       Date:  1995

3.  Neuron-specific enolase as a marker of brain metastasis in patients with small-cell lung carcinoma.

Authors:  M van de Pol; A Twijnstra; G P ten Velde; P P Menheere
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.

Authors:  P O'Shea; M Cassidy; R Freaney; P McCarthy; J Fennelly
Journal:  Ir J Med Sci       Date:  1995-01       Impact factor: 1.568

5.  A population pharmacodynamic model for lactate dehydrogenase and neuron specific enolase to predict tumor progression in small cell lung cancer patients.

Authors:  Núria Buil-Bruna; José-María López-Picazo; Marta Moreno-Jiménez; Salvador Martín-Algarra; Benjamin Ribba; Iñaki F Trocóniz
Journal:  AAPS J       Date:  2014-04-17       Impact factor: 4.009

6.  Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer.

Authors:  L G Jørgensen; F R Hirsch; B G Skov; K Osterlind; E H Cooper; L I Larsson
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

7.  Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?

Authors:  M Harding; J McAllister; G Hulks; D Vernon; R Monie; J Paul; S B Kaye
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

8.  Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer.

Authors:  A van der Gaast; W L van Putten; R Oosterom; M Cozijnsen; R Hoekstra; T A Splinter
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

9.  Distinction of two different classes of small-cell lung cancer cell lines by enzymatically inactive neuron-specific enolase.

Authors:  T A Splinter; C F Verkoelen; M Vlastuin; T C Kok; G Rijksen; K G Haglid; F Boomsma; A van de Gaast
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

10.  Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC).

Authors:  L G Jørgensen; K Osterlind; H H Hansen; E H Cooper
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.